| scholarly article | Q13442814 |
| P2093 | author name string | Thangadurai Maheswaran | |
| Nalliappan Ganapathy | |||
| Venkatesan | |||
| Nataraj Balan | |||
| Subramanium Gokulnathan | |||
| P2860 | cites work | Bisphosphonates: mechanism of action and role in clinical practice | Q24644708 |
| Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment | Q28278528 | ||
| Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. | Q34009569 | ||
| Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro | Q34793691 | ||
| Molecular mechanisms of action of bisphosphonates: current status. | Q36633778 | ||
| Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite | Q46620565 | ||
| Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? | Q46790362 | ||
| Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws | Q47997468 | ||
| The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws | Q48672321 | ||
| Recent recommendations on bisphosphonate-associated osteonecrosis of the jaw | Q81464250 | ||
| Bisphosphonates and osteonecrosis of the jaw--current thoughts | Q84656796 | ||
| P433 | issue | Suppl 2 | |
| P304 | page(s) | S410-3 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Journal of Pharmacy and Bioallied Sciences | Q6295744 |
| P1476 | title | Bisphosphonates: An update | |
| P478 | volume | 4 |
Search more.